UK DRI at the ARUK conference 2018
As one of our founding funders, we were proud to feature at this year's annual conference from Alzheimer's Research UK (March 20-21, London).
Read ArticleAll the latest developments
from the institute
Roger de Spoelberch Prize awarded to David Rubinsztein, UK DRI Professor
Awarded for work on neurodegenerative or psychiatric diseases, this year's prize goes to Prof David Rubinsztein, UK DRI at University of Cambridge, for his work on autophagy and neurodegeneration.
Read Article
Scottish government invest in MND at the UK DRI at Edinburgh
Almost £400,000 will be invested over the next three years to fund two postdoctoral posts.
Read Article
Official launch: UK DRI at the University of Edinburgh
In the first of our six openings this year, our Edinburgh centre set the bar exceptionally high!
Read Article
UK DRI centres at Edinburgh and Kings come together to provide new insight for ALS
This research represents an early step in our understanding of why motor neurons are highly vulnerable in ALS.
Read Article
£40 million boost to UK DRI hub at UCL
This new funding will contribute to an iconic £250m new building at UCL which will host the central hub of UK DRI alongside the university’s world-class Institute of Neurology (IoN).
Read Article
UK DRI leaders win the world’s top brain research prize
We’re over the moon that UK DRI Director Bart De Strooper and UK DRI Professor John Hardy have been awarded the world’s most valuable prize for brain research.
Read Article
In ‘failure’ there is knowledge
The UK DRI responds to the latest news that Merck is stopping a phase 3 trial in Alzheimer’s disease.
Read Article
UK DRI features in the MRC’s science showcase in Parliament
The showcase provided the opportunity to raise awareness among parliamentarians and policymakers of the importance of medical research to human health and wellbeing, innovation and economic growth.
Read Article
Our Edinburgh centre sheds new light on Motor Neurone Disease
A new study shows that a loss of synapses in the brain is linked to cognitive decline in ALS.
Read Article
Dementia is too big a problem to walk away from – for Pfizer or any of us
Our Director responds to Pfizer's decision to end their efforts in dementia drug discovery
Read Article
Can you sleep your way to a healthier brain?
Experts researching the science of sleep join the UK DRI and turn their attention to dementia for the first time.
Read Article
Awarding a new programme in Huntington’s disease
The £1.5m programme will be led by Professors Gillian Bates and Sarah Tabrizi from University College London (UCL) and will look to better understand the DNA damage that occurs as this neurodegenerative disease unfolds.
Read Article
Care & technology at the UK DRI: Improving lives today and tomorrow
We're seeking an inspirational associate director to lead an ambitious care & technology programme.
Read Article
Welcoming our Chairman: William Rucker
William will lead the UK DRI Board for the effective governance and development of the UK DRI, setting its strategic direction and major policies.
Read Article
UK DRI Professor Tara Spires-Jones sheds light on how damage spreads through the brain
The group in Edinburgh provide insights into how a key chemical disrupts brain cells in Dementia with Lewy Bodies.
Read Article
UK DRI Director wins the 2017 European Grand Prize for Research
Professor Bart De Strooper is recognised for his contributions to our understanding of Alzheimer's disease.
Read Article
Working together for a better future for people with dementia
On World Alzheimer's day, we take a fresh look at the dementia research landscape across the UK.
Read Article
UK DRI proud to be part of the Alzheimer's Association International Conference
The AAIC was hosted in London this year, giving the UK DRI a perfect opportunity to meet many researchers and share our vision.
Read Article
UK DRI Director Bart De Strooper finds new insight on anti-amyloid treatment
In a new paper published in Cell, the team provide novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’s disease.
Read Article